HolderBook

Squadron Capital Management LLC

Reported holdings as of Q2 2026, from 3 quarterly filings.

CIK
2050709
Reported value
$322.2M
Positions
38
Top 10 weight
67.8%
Filed
2026-08-14
Days after quarter end
45

Holdings

SecurityTickerValue SharesWeightWeight change Held Change
RELMADA THERAPEUTICS INCRLMD$50.9M7,350,00015.78%-5.83pp3q-13.3%-$7.8M
C4 THERAPEUTICS INC OPTCCCC$35.5M7,200,00011.01%+8.85pp2q+220.0%+$24.4M
COGENT BIOSCIENCES INCCOGT$33.5M865,00010.39%-0.72pp3q+9.8%+$3.0M
ZENTALIS PHARMACEUTICALS INC OPTZNTL$20.0M3,700,0006.21%+2.75pp2q+1.9%+$373.2K
KODIAK SCIENCES INCKOD$19.5M500,0006.05%+0.74pp3q+31.6%+$4.7M
RELAY THERAPEUTICS INCRLAY$18.1M970,0005.63%+2.63pp2q+44.2%+$5.6M
EDGEWISE THERAPEUTICS INCEWTX$11.8M290,0003.66%-0.38pp3q-17.1%-$2.4M
MAZE THERAPEUTICS INCMAZE$10.0M335,0003.10%+0.29pp3q+30.1%+$2.3M
BIOAGE LABS INC OPTBIOA$9.9M155,0003.08%-newNEW
INVENTIVA SAIVA$9.2M2,435,0002.86%+1.77pp3q+355.1%+$7.2M
ADLAI NORTYE LTDANL$8.8M764,8762.73%-0.48pp2q-39.5%-$5.8M
COMPASS PATHWAYS PLC OPTCMPS$8.6M300,0002.66%-newNEW
ENLIVEN THERAPEUTICS INCELVN$8.1M160,0002.52%-newNEW
REZOLUTE INC OPTRZLT$6.8M403,4102.10%-newNEW
ARRIVENT BIOPHARMA INC OPTAVBP$6.4Moptions only1.97%+1.04pp3qOPTIONS
PALISADE BIO INCPALI$6.3M3,000,0001.95%+0.02pp3qHELD
INHIBIKASE THERAPEUTICS INCIKT$6.1M3,000,0001.89%-0.26pp3q-14.3%-$1.0M
ADAGENE INCADAG$5.2M1,250,0001.63%-newNEW
FORTE BIOSCIENCES INCFBRX$4.8M225,0001.48%-newNEW
INFLARX NVIFRX$4.5M2,000,0001.39%-newNEW
ASSEMBLY BIOSCIENCES INCASMB$4.4M160,0001.36%-newNEW
PROMIS NEUROSCIENCES INCPMN$4.3M324,9771.33%-0.19pp2qHELD
CONTINEUM THERAPEUTICS INCCTNM$4.3M260,0001.32%-newNEW
DEFINIUM THERAPEUTICS INCDFTX$4.0M85,0001.24%-newNEW
SOL-GEL TECHNOLOGIES LTDSLGL$3.9M52,0001.20%+0.30pp2q+67.7%+$1.6M
SCYNEXIS INC$3.1M756,8840.96%-newNEW
PROQR THRAPEUTICS N VPRQR$2.8M1,511,4960.87%-newNEW
DISC MEDICINE INC OPTIRON$2.2Moptions only0.68%-newOPTIONS
LIPOCINE INC NEWLPCN$2.1M810,0000.64%-0.67pp3q+80.0%+$921.6K
ULTRAGENYX PHARMACEUTICAL IN OPTRARE$1.8Moptions only0.57%-newOPTIONS
CUE BIOPHARMA INCCUE$1.6M50,0000.49%-newNEW
CALCIMEDICA INCCALC$1.3M1,244,8640.40%-newNEW
QUINCE THERAPEUTICS INC$734.4K40,3750.23%-newNEW
NUVECTIS PHARMA INC OPTNVCT$711.7Koptions only0.22%-newOPTIONS
PASITHEA THERAPEUTICS CORPKTTA$515.4K1,000,0000.16%-0.41pp3q-52.4%-$566.9K
INMED PHARMACEUTICALS INCINM$503.8K325,0000.16%-newNEW
NEUMORA THERAPEUTICS INC.NMRA$170.0K100,0000.05%-newNEW
NEXTCURE INCNXTC$103.1K64,4640.03%-1.01pp3q-75.7%-$320.9K

By sector

Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.

Biotech & Pharma 98.8%Not classified 1.2%
 
SectorValueShare
Biotech & Pharma$318.4M98.8%
Not classified$3.8M1.2%

Quarter by quarter

QuarterValuePositions NewAddedTrimmed ExitedTop 10 Days to file
Q2 2026$322.2M3820961567.8%45
Q1 2026$272.9M3315871569.9%45
Q4 2025$236.0M33000065.7%48

Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.

Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.

Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.